Clinical Advisors

Daniel D. Von Hoff, M.D., F.A.C.P. : Clinical Advisor

  • Mayo Clinic, TGen, US Oncology.
  • Physician in Chief, Distinguished Professor, Director of Clinical Translational Research Division at TGen;
  • CSO, US Oncology Research;
  • Professor of Medicine, Mayo Clinic, Scottsdale, AZ.
  • Recognized expert in Oncology drug development;
  • PI on numerous phase I-III clinical trials including Abraxane; >620 papers, 137 book chapters
  • 2010 David A. Karnofsky Memorial Award from ASCO; Past President of the AACR; Appointed to President Bush’s National Cancer Advisory Board in 2004-2010.
  • Founder of ILEX™ Oncology.

Sant Chawla, MD, FRACP : Advisor, Oncology Programs

  • Director, Sarcoma Oncology Center, Santa Monica, CA.
  • Academic appointments and affiliations: Stanford Univ Medical Center, MD Anderson Cancer Center, David Geffen School of Medicine UCLA, Keck School of Medicine USC, Cedars Sinai Medical Center
  • Extensive Clinical trial experience (>30 yrs) : Phase 1-3. Pazopanib, Denosumab, Ridoforolimus (rapamycin analog), Palifosfomide, Aldoxorubicin, TH302, belinostat, ofatumumab, AMG655, MEK162 and others

James McKiernan, MD : Columbia University Medical Center

  • Chair, Department of Urology
  • John and Irene Given Professor of Urology, Herbert Irving Comprehensive Cancer Center
  • Recognized expert in treatment of early stage bladder cancer
  • PI, AADI Bladder cancer Phase I/II trial
  • > 130 publications
  • Investigator in numerous clinical trials

Mark Gladwin, MD : University of Pittsburgh School of Medicine [PAH]

  • Chief of the Pulmonary, Allergy and Critical Care Medicine Division
  • Recognized expert in pulmonary hypertension and sickle cell disease
  • PI, AADI Pulmonary Hypertension Phase I/II trial
  • > 200 publications
  • Investigator in > 25 clinical trials